手部湿疹局部外用糖皮质激素治疗2周后皮肤微生物组的变化
该研究纳入31例中重度慢性手部湿疹患者,在局部外用糖皮质激素(TCS)治疗2周前后采集皮损与非皮损部位细菌样本,行16S rRNA和tuf基因测序,并以手部湿疹严重度指数(HECSI)评估病情。结果显示皮损菌群组成与非皮损不同,金黄色葡萄球菌相对丰度更高,治疗后随病情改善向非皮损菌群特征转变。
要点
- 手部湿疹皮损菌群组成与非皮损存在差异,金黄色葡萄球菌相对丰度升高。
- 局部外用糖皮质激素治疗2周后,皮损菌群向非皮损特征转变。
- 结果提示抗金黄色葡萄球菌策略可能是未来治疗方向。
核心结论
- 手部湿疹皮损的细菌性皮肤微生物组发生改变,部分由金黄色葡萄球菌定植驱动,治疗后向非皮损皮肤转变。
研究设计与样本
- 研究纳入31例中重度慢性手部湿疹患者并进行随访。
- 在局部外用糖皮质激素治疗2周前后,从皮损和非皮损皮肤采集细菌样本。
- 采用ESwabs采样,并行16S rRNA和tuf基因测序分析。
- 临床病情严重度采用手部湿疹严重度指数(HECSI)评估。
主要发现
- 与非皮损皮肤相比,皮损皮肤整体细菌群落组成存在差异(p = 0.02)。
- 皮损皮肤葡萄球菌属相对丰度更高,尤其是金黄色葡萄球菌(p = 0.01)。
- 皮损皮肤微球菌属相对丰度更低(p = 0.02)。
- 随着治疗病情改善,皮损皮肤的微生物特征向手部非皮损皮肤转变。
临床怎么用
- 局部外用糖皮质激素治疗2周可改善手部湿疹病情并伴随皮损菌群向非皮损特征转变。
- 金黄色葡萄球菌定植与手部湿疹皮损菌群改变相关,提示抗金黄色葡萄球菌策略值得进一步探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: More than 50% of patients with hand eczema (HE) are colonized with Staphylococcus aureus. Comprehensive knowledge of the skin microbiome and its changes in patients with HE may provide insights into future potential therapeutical targets. OBJECTIVE: To describe the skin microbiome in patients with moderate-to-severe chronic HE and assess its changes following treatment with topical corticosteroids (TCS). METHODS: Bacterial samples were collected from lesional and nonlesional skin before and after 2 weeks of TCS treatment using ESwabs and analysed by 16S rRNA and tuf gene sequencing. Clinically, the disease severity was assessed by the Hand Eczema Severity Index (HECSI). RESULTS: A cohort of 31 patients with HE were included and followed up. Compared to nonlesional skin, lesional skin differed in overall bacterial community composition (p = 0.02), displayed higher relative abundance of Staphylococcus, in particular S. aureus (p = 0.01) and lower abundance of Micrococcus (p = 0.02). As disease severity improved with treatment, these microbial characteristics on lesional skin shifted towards that of nonlesional skin on the hands. CONCLUSIONS: The bacterial skin microbiome was altered in lesions of HE and partly driven by S. aureus colonization, however, shifted towards nonlesional skin following treatment. Our results emphasize the future possibilities for anti-S. aureus treatment strategies.
引用
- Nørreslet LB, Ingham AC, Agner T, et al. Hand eczema and changes in the skin microbiome after 2 weeks of topical corticosteroid treatment. J Eur Acad Dermatol Venereol. 2024. PMID: 39360671. doi:10.1111/jdv.20366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。